| Record ID | ia:cardiovascularph0000unse_g9v0 |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/cardiovascularph0000unse_g9v0/cardiovascularph0000unse_g9v0_marc.xml |
| Download MARC binary | https://www.archive.org/download/cardiovascularph0000unse_g9v0/cardiovascularph0000unse_g9v0_meta.mrc |
LEADER: 03406cam 2200625Ia 4500
001 ocn688999664
003 OCoLC
005 20220721142815.0
008 101203s2010 caua ob 001 0 eng d
006 m o d
007 cr cnu---unuuu
040 $aN$T$beng$epn$cN$T$dAU@$dOCLCQ$dOPELS$dOCLCQ$dOCLCF$dOHS$dYDXCP$dOCLCQ$dOCLCO$dOCLCQ$dESU$dD6H$dLEAUB$dOCLCO$dOL$$dOCLCQ$dOCLCA$dOCLCO
016 7 $a015623145$2Uk
019 $a679855994
020 $a9780123849045$q(electronic bk.)
020 $a0123849047$q(electronic bk.)
020 $a9780123849038$q(electronic bk.)
020 $a0123849039$q(electronic bk.)
035 $a(OCoLC)688999664$z(OCoLC)679855994
050 4 $aRM30$b.A4eb vol. 59
060 4 $aQV 150
072 7 $aMED$x071000$2bisacsh
082 04 $a615/.71$222
245 00 $aCardiovascular pharmacology :$bheart and circulation /$ceditor, Paul M. Vanhoutte.
250 $a1st ed.
260 $aSan Diego, CA ;$aLondon :$bAcademic,$c2010.
300 $a1 online resource (xii, 331 pages) :$billustrations
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
490 1 $aAdvances in pharmacology ;$vv. 59
504 $aIncludes bibliographical references and index.
588 0 $aPrint version record.
520 $aCardiovascular disease remains a major cause of death and disability in developed countries and, increasingly so, in the developing world. Presented in this volume of Advances in Pharmacology are some of the most promising possibilities for treating large numbers of individuals afflicted with these conditions This volume contains up-to-date reviews of the most important emerging cardiovascular therapies written by world leaders in the field.
505 0 $aCover; Cardiovascular Pharmacology: Heart and Circulation; Contents; Contributors; Foreword; The Ryanodine Receptor in Cardiac Physiology and Disease; Neuregulin-1/ErbB Signaling and Chronic Heart Failure; If Inhibition in Cardiovascular Diseases; Pharmacology of Cardiac Potassium Channels; Beta3-Adrenergic Receptors in Cardiacand Vascular Tissues: Emerging Conceptsand Therapeutic Perspectives; Modulation of Vascular Sarco/Endoplasmic Reticulum Calcium ATPase in Cardiovascular Pathophysiology.
650 0 $aCardiovascular pharmacology.
650 0 $aCardiovascular agents.
650 2 $aCardiovascular Agents
650 6 $aPharmacologie cardiovasculaire.
650 6 $aAgents cardiovasculaires.
650 7 $aMEDICAL$xPharmacology.$2bisacsh
650 7 $aCardiovascular pharmacology.$2fast$0(OCoLC)fst00847170
655 4 $aElectronic books.
700 1 $aVanhoutte, Paul M.
776 08 $iPrint version:$tCardiovascular pharmacology.$dLondon : Academic, 2010$z9780123849038$w(OCoLC)655650627
830 0 $aAdvances in pharmacology (San Diego, Calif.) ;$vv. 59.
856 40 $3EBSCOhost$uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=345030
856 40 $3ScienceDirect$uhttps://www.sciencedirect.com/science/book/9780123849038
856 40 $3ScienceDirect$uhttps://www.sciencedirect.com/science/bookseries/10543589/59
938 $aEBSCOhost$bEBSC$n345030
938 $aYBP Library Services$bYANK$n3535009
029 1 $aAU@$b000046163396
029 1 $aDEBSZ$b405335342
994 $aZ0$bIME
948 $hNO HOLDINGS IN IME - 175 OTHER HOLDINGS